Inhibrx Total Current Assets from 2010 to 2024

INBX Stock  USD 14.86  0.78  5.54%   
Inhibrx Total Current Assets yearly trend continues to be fairly stable with very little volatility. Total Current Assets are likely to outpace its year average in 2024. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2019-03-31
Previous Quarter
242.1 M
Current Value
207.4 M
Quarterly Volatility
103.6 M
 
Covid
Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 33.4 M, Minority Interest of 0.0 or Tax Provision of 2.6 K, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0021 or PTB Ratio of 43.23. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.
  
Check out the analysis of Inhibrx Correlation against competitors.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Latest Inhibrx's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Inhibrx over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Inhibrx's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Inhibrx Total Current Assets Regression Statistics

Arithmetic Mean89,118,393
Geometric Mean39,665,628
Coefficient Of Variation128.36
Mean Deviation94,889,191
Median20,408,000
Standard Deviation114,395,613
Sample Variance13086.4T
Range304.5M
R-Value0.80
Mean Square Error4966.2T
R-Squared0.65
Significance0.0003
Slope20,585,048
Total Sum of Squares183209T

Inhibrx Total Current Assets History

2024310.1 M
2023295.4 M
2022280.5 M
2021139.1 M
2020132.2 M
201915.6 M
20185.7 M

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's Total Current Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets295.4 M310.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.